Literature DB >> 9924344

Accumulation of tissue inhibitor of metalloproteinases-3 in human eyes with Sorsby's fundus dystrophy or retinitis pigmentosa.

R N Fariss1, S S Apte, P J Luthert, A C Bird, A H Milam.   

Abstract

BACKGROUND/AIMS: Tissue inhibitor of metalloproteinases-3 (TIMP-3) is normally synthesised by the retinal pigment epithelium (RPE) and deposited in Bruch's membrane. Mutations in the TIMP3 gene cause Sorsby's fundus dystrophy (SFD), which is characterised by thickening of Bruch's membrane, choroidal neovascularisation, and photoreceptor degeneration. To elucidate the role of TIMP-3 in human retinal degenerative diseases, we immunolocalised TIMP-3 in eyes with SFD caused by the Ser-181-Cys TIMP3 gene mutation or retinitis pigmentosa (RP; not caused by TIMP3 mutations).
METHODS: Standard light microscopic immunocytochemistry, including antigen retrieval, was used to localise TIMP-3 in paraffin sections of human eyes: two with SFD, three with different genetic forms of RP, and two normal.
RESULTS: In the SFD eyes, the thickened Bruch's membrane was strongly TIMP-3 positive except where RPE cells had degenerated. Similarly, in the RP eyes, Bruch's membrane was TIMP-3 positive except where RPE cells were lost, consistent with ongoing RPE mediated turnover of TIMP-3 in this region. In areas of total photoreceptor loss, migrated RPE cells formed cuffs around blood vessels in the RP retinas. Thick, TIMP-3 positive extracellular matrix (ECM) deposits associated with the migrated RPE cells occluded some vascular lumina, correlating with the observed loss of inner retinal neurons in RP.
CONCLUSIONS: TIMP-3 is a component of the increased ECM sequestered in Bruch's membrane in SFD. Further information is needed on normal TIMP-3/ECM interactions in Bruch's membrane and the effect of mutant TIMP-3 on this process. The finding of TIMP-3 accumulations in retinas with RP not caused by TIMP-3 mutations emphasises the importance of ECM remodelling in normal and diseased human eyes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9924344      PMCID: PMC1722431          DOI: 10.1136/bjo.82.11.1329

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  36 in total

1.  Morphometric analysis of macular photoreceptors and ganglion cells in retinas with retinitis pigmentosa.

Authors:  J L Stone; W E Barlow; M S Humayun; E de Juan; A H Milam
Journal:  Arch Ophthalmol       Date:  1992-11

2.  A fundus dystrophy with unusual features.

Authors:  A SORSBY; M E J MASON
Journal:  Br J Ophthalmol       Date:  1949-02       Impact factor: 4.638

3.  Sorsby's fundus dystrophy. A light and electron microscopic study.

Authors:  M R Capon; J Marshall; J I Krafft; R A Alexander; P S Hiscott; A C Bird
Journal:  Ophthalmology       Date:  1989-12       Impact factor: 12.079

4.  Vitamin A megatherapy for retinal abnormalities.

Authors:  T S Acott; R G Weleber
Journal:  Nat Med       Date:  1995-09       Impact factor: 53.440

5.  Abnormal dark adaptation and rhodopsin kinetics in Sorsby's fundus dystrophy.

Authors:  R L Steinmetz; P C Polkinghorne; F W Fitzke; C M Kemp; A C Bird
Journal:  Invest Ophthalmol Vis Sci       Date:  1992-04       Impact factor: 4.799

6.  Night blindness in Sorsby's fundus dystrophy reversed by vitamin A.

Authors:  S G Jacobson; A V Cideciyan; G Regunath; F J Rodriguez; K Vandenburgh; V C Sheffield; E M Stone
Journal:  Nat Genet       Date:  1995-09       Impact factor: 38.330

7.  A new inhibitor of metalloproteinases from chicken: ChIMP-3. A third member of the TIMP family.

Authors:  N Pavloff; P W Staskus; N S Kishnani; S P Hawkes
Journal:  J Biol Chem       Date:  1992-08-25       Impact factor: 5.157

8.  Increased expression of retinal TIMP3 mRNA in simplex retinitis pigmentosa is localized to photoreceptor-retaining regions.

Authors:  C Jomary; M J Neal; S E Jones
Journal:  J Neurochem       Date:  1995-05       Impact factor: 5.372

9.  Sorsby's fundus dystrophy. A clinical study.

Authors:  P J Polkinghorne; M R Capon; T Berninger; A L Lyness; K Sehmi; A C Bird
Journal:  Ophthalmology       Date:  1989-12       Impact factor: 12.079

10.  Sorsby's pseudoinflammatory macula dystrophy--Sorsby's fundus dystrophies.

Authors:  M R Capon; P J Polkinghorne; F W Fitzke; A C Bird
Journal:  Eye (Lond)       Date:  1988       Impact factor: 3.775

View more
  32 in total

Review 1.  Matrix metalloproteinase biology applied to vitreoretinal disorders.

Authors:  C S Sethi; T A Bailey; P J Luthert; N H Chong
Journal:  Br J Ophthalmol       Date:  2000-06       Impact factor: 4.638

2.  Clinical features of a novel TIMP-3 mutation causing Sorsby's fundus dystrophy: implications for disease mechanism.

Authors:  M Clarke; K W Mitchell; J Goodship; S McDonnell; M D Barker; I D Griffiths; N McKie
Journal:  Br J Ophthalmol       Date:  2001-12       Impact factor: 4.638

3.  Sorsby fundus dystrophy presenting with choroidal neovascularisation showing good response to steroid treatment.

Authors:  D Atan; C Y Gregory Evans; D Louis; S M Downes
Journal:  Br J Ophthalmol       Date:  2004-03       Impact factor: 4.638

4.  A novel TIMP3 mutation associated with a retinitis pigmentosa-like phenotype.

Authors:  Meghan J DeBenedictis; Yosef Gindzin; Enrico Glaab; Bela Anand-Apte
Journal:  Ophthalmic Genet       Date:  2020-07-27       Impact factor: 1.803

5.  Tissue inhibitor of metalloproteinase-3 differentially binds to components of Bruch's membrane.

Authors:  M A Majid; V A Smith; F J Matthews; A C Newby; A D Dick
Journal:  Br J Ophthalmol       Date:  2006-07-12       Impact factor: 4.638

6.  Matrix bound SFD mutant TIMP-3 is more stable than wild type TIMP-3.

Authors:  Mohammed A Majid; Valerie A Smith; Andrew C Newby; Andrew D Dick
Journal:  Br J Ophthalmol       Date:  2007-03-23       Impact factor: 4.638

7.  Identification of novel retinal target genes of thyroid hormone in the human WERI cells by expression microarray analysis.

Authors:  Yan Liu; Li Fu; Ding-Geng Chen; Samir S Deeb
Journal:  Vision Res       Date:  2007-07-25       Impact factor: 1.886

8.  Adenovirus mediated gene delivery of tissue inhibitor of metalloproteinases-3 induces death in retinal pigment epithelial cells.

Authors:  Mohammed A Majid; Valerie A Smith; David L Easty; Andrew H Baker; Andrew C Newby
Journal:  Br J Ophthalmol       Date:  2002-01       Impact factor: 4.638

9.  Characterization of the gelatinase system of the laminar human optic nerve, and surrounding annulus of Bruch's membrane, choroid, and sclera.

Authors:  Ali A Hussain; Yunhee Lee; Jin-Jun Zhang; John Marshall
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-04-15       Impact factor: 4.799

10.  Influence of TIMP3/SYN3 polymorphisms on the phenotypic presentation of age-related macular degeneration.

Authors:  Daniel Ardeljan; Catherine B Meyerle; Elvira Agron; Jie Jin Wang; Paul Mitchell; Emily Y Chew; Jing Zhao; Arvydas Maminishkis; Chi-Chao Chan; Jingsheng Tuo
Journal:  Eur J Hum Genet       Date:  2013-02-20       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.